Soluble ligands and their receptors in human embryo development and implantation

Endocrine Reviews

Volumn 36, Issue 1, 2015, Pages 92-130

  Thouas, George A ^a   Dominguez, Francisco ^b,c   Green, Mark P ^a   Vilella, Felipe ^b,c   Simon, Carlos ^b,c,d   Gardner, David K ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HORMONE RECEPTOR; LIGAND; MICRORNA; RECEPTOR;

CYTOKINE RELEASE; EMBRYO DEVELOPMENT; ENDOMETRIUM; GENE EXPRESSION; HORMONE RELEASE; HUMAN; HUMAN EMBRYO; IN VITRO STUDY; INFERTILITY THERAPY; NIDATION; NONHUMAN; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REPRODUCTION; REVIEW; UTERINE TUBE;

EID: 84963940760     PISSN: None     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2014-1046     Document Type: Review

References (368)

1. Hartshorne GM, Edwards RG. Role of embryonic factors in implantation: recent developments. Baillieres Clin Obstet Gynaecol. 1991;5(1):133-158.
2. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet. 1978;2(8085):366.
3. Niakan KK, Eggan K. Analysis of human embryos from zygote to blastocyst reveals distinct gene expression patterns relative to the mouse. Dev Biol. 2013;375(1):54-64.
4. Gardner DK, Schoolcraft WB, Wagley L, Schlenker T, Stevens J, Hesla J.Aprospective randomized trial of blastocyst culture and transfer in in-vitro fertilization. Hum Reprod. 1998;13(12):3434-3440.
5. Hardy K, Spanos S. Growth factor expression and function in the human and mouse preimplantation embryo. J Endocrinol. 2002;172(2):221-236.
6. Richter KS. The importance of growth factors for preimplantation embryo development and in-vitro culture. Curr Opin Obstet Gynecol. 2008;20(3):292-304.
7. Kaye PL. Preimplantation growth factor physiology. Rev Reprod. 1997;2(2):121-127.
8. Lippes J, Krasner J, Alfonso LA, Dacalos ED, Lucero R. Human oviductal fluid proteins. Fertil Steril. 1981;36(5): 623-629.
9. Leese HJ. The formation and function of oviduct fluid. J Reprod Fertil. 1988;82(2):843-856.
10. Roberts GP, Parker JM, Henderson SR. Proteins in human uterine fluid. J Reprod Fertil. 1976;48(1):153-157.
11. Wolf DP, Mastroianni L Jr. Protein composition of human uterine fluid. Fertil Steril. 1975;26(3):240-247.
12. Bell SC, Drife JO. Secretory proteins of the endometrium- potential markers for endometrial dysfunction. Baillieres Clin Obstet Gynaecol. 1989;3(2):271-291.
13. Seppälä M, Julkunen M, Riittinen L, Koistinen R. Endometrial proteins: a reappraisal. Hum Reprod. 1992; 7(suppl 1):31-38.
14. Armant DR. Blastocysts don't go it alone. Extrinsic signals fine-tune the intrinsic developmental program of trophoblast cells. Dev Biol. 2005;280(2):260-280.
15. Kawamura K, Chen Y, Shu Y, et al. Promotion of human early embryonic development and blastocyst outgrowth in vitro using autocrine/paracrine growth factors. PLoS One. 2012;7(11):e49328.
16. Carpenter G, Wahl MI. The epidermal growth factor family. In: Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors. Vol 1. New York, NY: Springer- Verlag; 1991:69-171.
17. Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev. 1996;76(4):1005-1026.
18. Chia CM, Winston RM, Handyside AH. EGF, TGF-α and EGFR expression in human preimplantation embryos. Development. 1995;121(2):299-307.
19. Drakakis P, Vlismas A, Partsinevelos G, et al. Gene expression of hormones and hormone receptors and growth factors and receptors in 8-cell human embryos-their role in early embryonic development. Hum Reprod. 2010; 25(suppl 1):O-014, i013-016.
20. Katz-Jaffe MG, Gardner DK, Schoolcraft WB. Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability. Fertil Steril. 2006;85(1):101-107.
21. Smotrich DB, Stillman RJ, Widra EA, et al. Immunocytochemical localization of growth factors and their receptors in human pre-embryos and fallopian tubes. Hum Reprod. 1996;11(1):184-190.
22. Lighten AD, Hardy K, Winston RM, Moore GE. Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos. Mol Reprod Dev. 1997;47(2):134-139.
23. Lighten AD, Hardy K, Winston RM, Moore GE. IGF2 is parentally imprinted in human preimplantation embryos. Nat Genet. 1997;15(2):122-123.
24. Liu HC, He ZY, Mele CA, Veeck LL, Davis OK, Rosenwaks Z. Expression of IGFs and their receptors is a potential marker for embryo quality. Am J Reprod Immunol. 1997;38(4):237-245.
25. Liu HC, He ZY, Tang YX, et al. Simultaneous detection of multiple gene expression in mouse and human individual preimplantation embryos. Fertil Steril. 1997;67(4):733-741.
26. Osterlund C, Wramsby H, Pousette A. Temporal expression of platelet-derived growth factor (PDGF)-A and its receptor in human preimplantation embryos. Mol Hum Reprod. 1996;2(7):507-512.
27. Krüssel J, Behr B, Hirchenhain J, et al. Expression of vascular endothelial growth factor mRNA in human preimplantation embryos derived from tripronuclear zygotes. Fertil Steril. 2000;74(6):1220-1226.
28. Krüssel JS, Behr B, Milki AA, et al. Vascular endothelial growth factor (VEGF) mRNA splice variants are differentially expressed in human blastocysts. Mol Hum Reprod. 2001;7(1):57-63.
29. Hwu YM, Chen CP, Li SH, Chen PW, Lee RK, Fleming S. Expression of vascular endothelial growth factor messenger ribonucleic acid and protein in human preimplantation embryos. Fertil Steril. 2006;85(6):1830-1832.
30. Svalander PC, Holmes PV, OlovssonM,WiklandM,Gemzell- Danielsson K, Bygdeman M. Platelet-derived growth factor is detected in human blastocyst culture medium but not in human follicular fluid-a preliminary report. Fertil Steril. 1991;56(2):367-369.
31. Hemmings R, Langlais J, Falcone T, Granger L, Miron P, Guyda H. Human embryos produce transforming growth factors α activity and insulin-like growth factors II. Fertil Steril. 1992;58(1):101-104.
32. Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: Coordinators of immune and inflammatory responses. Ann Rev Biochem. 1990;59:783-836.
33. Zolti M, Ben-Rafael Z, Meirom R, et al. Cytokine involvement in oocytes and early embryos. Fertil Steril. 1991; 56(2):265-272.
34. Sharkey AM, Dellow K, Blayney M, Macnamee M, Charnock- Jones S, Smith SK. Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos. Biol Reprod. 1995;53(4):974-981.
35. Chen HF, Shew JY,HoHN,HsuWL,Yang YS. Expression of leukemia inhibitory factor and its receptor in preimplantation embryos. Fertil Steril. 1999;72(4):713-719.
36. Harper MJ, Kudolo GB, Alecozay AA, Jones MA. Plateletactivating factor (PAF) and blastocyst-endometrial interactions. Prog Clin Biol Res. 1989;294:305-315.
37. Domínguez F, Gadea B, Esteban FJ, Horcajadas JA, Pellicer A, Simón C. Comparative protein-profile analysis of implanted versus non-implanted human blastocysts. Hum Reprod. 2008;23(9):1993-2000.
38. O'Neill C, Gidley-Baird AA, Pike IL, Saunders DM. Use of a bioassay for embryo-derived platelet-activating factor as a means of assessing quality and pregnancy potential of human embryos. Fertil Steril. 1987;47(6):969-975.
39. Collier M, O'Neill C, Ammit AJ, Saunders DM. Measurement of human embryo-derived platelet-activating factor (PAF) using a quantitative bioassay of platelet aggregation. Hum Reprod. 1990;5(3):323-328.
40. Punjabi U, Vereecken A, Delbeke L, et al. Embryo-derived platelet activating factor, a marker of embryo quality and viability following ovarian stimulation for in vitro fertilization. J In Vitro Fert Embryo Transf. 1990;7(6):321- 326.
41. Nakatsuka M, Yoshida N, Kudo T. Platelet activating factor in culture media as an indicator of human embryonic development after in-vitro fertilization. Hum Reprod. 1992;7(10):1435-1439.
42. Austgulen R, Arntzen KJ, Vatten LJ, Kahn J, Sunde A. Detection of cytokines (interleukin-1, interleukin-6, transforming growth factor-β) and soluble tumour necrosis factor receptors in embryo culture fluids during in-vitro fertilization. Hum Reprod. 1995;10(1):171-176.
43. Sheth KV, Roca GL, al-Sedairy ST, Parhar RS, Hamilton CJ, al-Abdul Jabbar F. Prediction of successful embryo implantation by measuring interleukin-1-α and immunosuppressive factor(s) in preimplantation embryo culture fluid. Fertil Steril. 1991;55(5):952-957.
44. Inés BarañaoR, Piazza A, Rumi LS, Polak de Fried E. Interleukin-1 β levels in human embryo culture supernatants and their predictive value for pregnancy. Early Hum Dev. 1997;48:71-80.
45. Barañao RI, Piazza A, Rumi LS, Polak de Fried E. Determination of IL-1 and IL-6 levels in human embryo cultureconditioned media. Am J Reprod Immunol. 1997;37(2): 191-194.
46. De los Santos MJ, Mercader A, Francés A, et al. Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development. Biol Reprod. 1996;54(3):563-574.
47. Ozörnek MH, Bielfeld P, Krüssel JS, et al. Interferon γ and interleukin 10 levels in preimplantation embryo culture media. J Assist Reprod Genet. 1995;12(9):590-593.
48. Phocas I, Sarandakou A, Rizos D, Dimitriadou F, Mantzavinos T, Zourlas PA. Secretion of α-immunoreactive inhibin by human pre-embryos cultured in vitro. Hum Reprod. 1992;7(4):545-549.
49. Jones KP, Warnock SH, Urry RL, Edwin SS, Mitchell MD. Immunosuppressive activity and α interferon concentra tions in human embryo culture media as an index of potential for successful implantation. Fertil Steril. 1992; 57(3):637-640.
50. Ozornek MH, Bielfeld P, Krüssel JS, Cupisti S, Jeyendran RS, Koldovsky U. Interferon-γ production by the human preimplantation embryo. Am J Reprod Immunol. 1997; 37(6):435-437.
51. Smart YC, Cripps AW, Clancy RL, Roberts TK, Lopata A, Shutt DA. Detection of an immunosuppressive factor in human preimplantation embryo cultures. Med J Aust. 1981;1(2):78-79.
52. Morton H, Rolfe B, Clunie GJ. An early pregnancy factor detected inhumanserum by the rosette inhibition test. Lancet. 1977;1(8008):394-397.
53. Cavanagh AC. Identification of early pregnancy factor as chaperonin 10: implications for understanding its role. Rev Reprod. 1996;1(1):28-32.
54. Corrao S, Campanella C, Anzalone R, et al. Human Hsp10 and early pregnancy factor (EPF) and their relationship and involvement in cancer and immunity: current knowledge and perspectives. Life Sci. 2010;86:145-152.
55. Cocchiara R, di Trapani G, Azzolina A, Albeggiani G, Geraci D. Isolation of a histamine-releasing factor from two-cell human embryo. Int Arch Allergy Appl Immunol. 1987;84(3):321-323.
56. Bose R, Mahadevan MM. Embryo associated immunosuppressor factor (EASF) and serum estradiol synergism in pre-embryonic development after in vitro fertilization. Immunol Lett. 1996;52(1):15-22.
57. Dimitriadou F, Phocas I, Mantzavinos T, Sarandakou A, Rizos D, Zourlas PA. Discordant secretion of pregnancy specificβ 1-glycoprotein and human chorionic gonadotropin by human pre-embryos cultured in vitro. Fertil Steril. 1992;57(3):631-636.
58. Jurisicova A, Antenos M, Kapasi K, Meriano J, Casper RF. Variability in the expression of trophectodermal markers β-human chorionic gonadotrophin, human leukocyte antigen- G and pregnancy specific β-1 glycoprotein by the human blastocyst. Hum Reprod. 1999;14(7):1852-1858.
59. Roussev RG, Coulam CB, Kaider BD, Yarkoni M, Leavis PC, Barnea ER. Embryonic origin of preimplantation factor (PIF): biological activity and partial characterization. Mol Hum Reprod. 1996;2(11):883-887.
60. Katz-Jaffe MG, Schoolcraft WB, Gardner DK. Analysis of protein expression (secretome) by human and mouse preimplantation embryos. Fertil Steril. 2006;86(3):678-685.
61. Jurisicova A, Casper RF, MacLusky NJ, Mills GB, Librach CL. HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci USA. 1996; 93(1):161-165.
62. Balaban B, Urman B. Comparison of two sequential media for culturing cleavage-stage embryos and blastocysts: embryo characteristics and clinical outcome. Reprod Biomed Online. 2005;10(4):485-491.
63. Wunder DM, Birkhäuser MH, Bersinger NA. Soluble human leukocyte antigen-G (sHLA-G) in follicular fluid and embryo culture medium and its impact on pregnancy prediction in IVF-ICSI treatment. Immuno-Anal Biol Spec. 2013;28(1):43-50.
64. Fishel SB, Edwards RG, Evans CJ. Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro. Science. 1984;223(4638):816-818.
65. Hay DL, Lopata A. Chorionic gonadotropin secretion by human embryos in vitro. J Clin Endocrinol Metab. 1988; 67(6):1322-1324.
66. Dokras A, Sargent IL, Ross C, Gardner RL, Barlow DH. The human blastocyst: morphology and human chorionic gonadotrophin secretion in vitro.HumReprod. 1991;6(8): 1143-1151.
67. Bonduelle ML, Dodd R, Liebaers I, Van Steirteghem A, Williamson R, Akhurst R. Chorionic gonadotrophin-β mRNA,a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. Hum Reprod. 1988;3(7):909-914.
68. RamuS, Acacio B, AdamowiczM,Parrett S, Jeyendran RS. Human chorionic gonadotropin from day 2 spent embryo culture media and its relationship to embryo development. Fertil Steril. 2011;96(3):615-617.
69. Woodward BJ, Lenton EA, Turner K, Grace WF. Embryonic human chorionic gonadotropin secretion and hatching: poor correlation with cleavage rate and morphological assessment during preimplantation development in vitro. Hum Reprod. 1994;9(10):1909-1914.
70. Woodward BJ, Lenton EA, Turner K. Human chorionic gonadotrophin: embryonic secretion is a time-dependent phenomenon. Hum Reprod. 1993;8(9):1463-1468.
71. Lopata A, Oliva K, Stanton PG, Robertson DM. Analysis of chorionic gonadotrophin secreted by cultured human blastocysts. Mol Hum Reprod. 1997;3(6):517-521.
72. Butler SA, Luttoo J, Freire MO, Abban TK, Borrelli PT, Iles RK. Human chorionic gonadotropin (hCG) in the secretome of cultured embryos: hyperglycosylated hCG and hCG-free β subunit are potential markers for infertility management and treatment. Reprod Sci. 2013;20(9): 1038-1045.
73. Sugihara K, Kabir-Salmani M, Byrne J, et al. Induction of trophinin in human endometrial surface epithelia by CGβ and IL-1β. FEBS Lett. 2008;582(2):197-202.
74. Paiva P, Hannan NJ, Hincks C, et al. Human chorionic gonadotrophin regulates FGF2 and other cytokines produced by human endometrial epithelial cells, providing a mechanism for enhancing endometrial receptivity. Hum Reprod. 2011;26(5):1153-1162.
75. Kayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A.Humanchorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol. 2003;171(5):2305- 2313.
76. Casañ EM, Raga F, Polan ML. GnRH mRNA and protein expression in human preimplantation embryos. Mol Hum Reprod. 1999;5(3):234-239.
77. Cervero A, Horcajadas JA, Domínguez F, Pellicer A, Simón C. Leptin system in embryo development and implantation: a protein in search of a function. Reprod Biomed Online. 2005;10(2):217-223.
78. Suh N, Blelloch R. Small RNAs in early mammalian development: from gametes to gastrulation. Development. 2011;138(9):1653-1661.
79. Jing Q, Huang S, Guth S, et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell. 2005;120(5):623-634.
80. Asirvatham AJ, Magner WJ, Tomasi TB. miRNA regulation of cytokine genes. Cytokine. 2009;45(2):58-69.
81. McCoy CE. The role of miRNAs in cytokine signaling. Front Biosci (Landmark Ed). 2011;16:2161-2171.
82. McCallie B, Schoolcraft WB, Katz-Jaffe MG. Aberration of blastocyst microRNA expression is associated with human infertility. Fertil Steril. 2010;93(7):2374-2382.
83. Rosenbluth EM, Shelton DN, Sparks AE, Devor E, Christenson L, Van Voorhis BJ. MicroRNA expression in the human blastocyst. Fertil Steril. 2013;99(3):855-861.e3.
84. Rosenbluth EM, Wells LM, Sparks AE, Van Voorhis BJ. MicroRNA in culture media from human blastocysts exhibits a distinct signature that correlates with embryonic chromosomes and IVF outcome. Hum Reprod. 2012; 27(suppl 2):ii344 -ii348.
85. Mains LM, Christenson L, Yang B, Sparks AE, Mathur S, Van Voorhis BJ. Identification of apolipoprotein A1 in the human embryonic secretome. Fertil Steril. 2011;96(2): 422-427.e2.
86. Witkin SS, Liu HC, Davis OK, Rosenwaks Z. Tumor necrosis factor is present in maternal sera and embryo culture fluids during in vitro fertilization. J Reprod Immunol. 1991;19(1):85-93.
87. Khamsi F, Armstrong DT, Zhang X. Expression of urokinase-type plasminogen activator in human preimplantation embryos. Mol Hum Reprod. 1996;2(4):273-276.
88. McReynolds S, Vanderlinden L, Stevens J, Hansen K, Schoolcraft WB, Katz-Jaffe MG. Lipocalin-1: a potential marker for noninvasive aneuploidy screening. Fertil Steril. 2011;95(8):2631-2633.
89. Fuzzi B, Rizzo R, Criscuoli L, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol. 2002;32(2):311-315.
90. Cocchiara R, Di Trapani G, Azzolina A, Albeggiani G, Geraci D. Identification of a histamine-releasing factor secreted by human pre-implantation embryos grown in vitro. J Reprod Immunol. 1988;13(1):41-52.
91. Adjaye J, Bolton V,MonkM.Developmental expression of specific genes detected in high-qualitycDNAlibraries from single human preimplantation embryos. Gene. 1999; 237(2):373-383.
92. Thouas GA, Gardner DK. Metabolomic profiling for selection of the most viable embryos in clinical IVF. Curr Wom Health Rev. 2010;6(3):254-260.
93. Gott AL, Hardy K, Winston RM, Leese HJ. Non-invasive measurement of pyruvate and glucose uptake and lactate production by single human preimplantation embryos. Hum Reprod. 1990;5(1):104-108.
94. Butcher L, Coates A, Martin KL, Rutherford AJ, Leese HJ. Metabolism of pyruvate by the early human embryo. Biol Reprod. 1998;58(4):1054-1056.
95. Conaghan J, Hardy K, Leese HJ, Winston RM, Handyside AH. Culture of human preimplantation embryos to the blastocyst stage: a comparison of 3 media. Int J Dev Biol. 1998;42(7):885-893.
96. Jones GM, Trounson AO, Vella PJ, Thouas GA, Lolatgis N, Wood C. Glucose metabolism of human morula and blastocyst-stage embryos and its relationship to viability after transfer. Reprod Biomed Online. 2001;3(2):124-132.
97. Sánchez-Ribas I, Riqueros M, Vime P, et al. Differential metabolic profiling of non-pure trisomy 21 human preimplantation embryos. Fertil Steril. 2012;98(5):1157- 1164.e1-e2.
98. Gardner DK, Lane M, Stevens J, Schoolcraft WB. Noninvasive assessment of human embryo nutrient consumption as a measure of developmental potential. Fertil Steril. 2001; 76(6):1175-1180.
99. Wales RG, Whittingham DG, Hardy K, Craft IL. Metabolism of glucose by human embryos. J Reprod Fertil. 1987; 79(1):289-297.
100. Houghton FD, Hawkhead JA, Humpherson PG, et al. Non-invasive amino acid turnover predicts human embryo developmental capacity. Hum Reprod. 2002;17(4):999-1005.
101. Zhao Q, Yin T, Peng J, et al. Noninvasive metabolomic profiling of human embryo culture media using a simple spectroscopy adjunct to morphology for embryo assessment in in vitro fertilization (IVF). Int J Mol Sci. 2013; 14(4):6556-6570.
102. Cikos S, Fabian D, Makarevich AV, Chrenek P, Koppel J. Biogenic monoamines in preimplantation development. Hum Reprod. 2011;26(9):2296-2305.
103. Cocchiara R, Albeggiani G, Di Trapani G, et al. Oestradiol enhances in vitro the histamine release induced by embryonic histamine-releasing factor (EHRF) from uterine mast cells. Hum Reprod. 1992;7(8):1036-1041.
104. Kubisch HM, Johnson KM. The effects of blastomere biopsy and oxygen tension on bovine embryo development, rate of apoptosis and interferon-γ secretion. Reprod Domest Anim. 2007;42(5):509-515.
105. Kind KL, Collett RA, Harvey AJ, Thompson JG. Oxygenregulated expression of GLUT-1, GLUT-3, and VEGF in the mouse blastocyst. Mol Reprod Dev. 2005;70(1): 37-44.
106. Lane M, Gardner DK. Selection of viable mouse blastocysts prior to transfer using a metabolic criterion. Hum Reprod. 1996;11(9):1975-1978.
107. Brosens JJ, Salker MS, Teklenburg G, et al. Uterine selection of human embryos at implantation. Sci Rep. 2014;4: 3894.
108. O'Neill C, Li Y, Jin XL. Survival signaling in the preimplantation embryo. Theriogenology. 2012;77(4):773-784.
109. Edwards RG, Beard HK. Oocyte polarity and cell determination in early mammalian embryos. Mol Hum Reprod. 1997;3(10):863-905.
110. Antczak M, Van Blerkom J. Oocyte influences on early development: the regulatory proteins leptin and STAT3 are polarized in mouse and human oocytes and differentially distributed within the cells of the preimplantation stage embryo. Mol Hum Reprod. 1997;3(12):1067-1086.
111. Jiang Q, Chen S, Xing F. Expression of epidermal growth factor receptor in human preimplantation embryos [in Chinese]. Zhonghua Fu Chan Ke Za Zhi. 2000;35(8):468-469.
112. He ZY, Liu HC, Mele CA, et al. Expression of inhibin/ activin subunits and their receptors and binding proteins in human preimplantation embryos. J Assist Reprod Genet. 1999;16(2):73-80.
113. Kubota T, Kamada S, Ohara M, et al. Insulin-like growth factor II in follicular fluid of the patients with in vitro fer tilization and embryo transfer. Fertil Steril. 1993;59(4): 844-849.
114. Geisthovel F, Moretti-Rojas I, Asch RH, Rojas FJ. Expression of insulin-like growth factor-II (IGF-II) messenger ribonucleic acid (mRNA), but not IGF-I mRNA, in human preovulatory granulosa cells. Hum Reprod. 1989;4(8): 899-902.
115. Chobotova K, Spyropoulou I, Carver J, et al. Heparinbinding epidermal growth factor and its receptor ErbB4 mediate implantation of the human blastocyst. Mech Dev. 2002;119(2):137-144.
116. Threadgill DW, Dlugosz AA, Hansen LA, et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 1995;269(5221): 230-234.
117. Liu HC, He ZY, Mele CA, Veeck LL, Davis O, Rosenwaks Z. Human endometrial stromal cells improve embryo quality by enhancing the expression of insulin-like growth factors and their receptors in cocultured human preimplantation embryos. Fertil Steril. 1999;71(2):361-367.
118. van Eijk MJ, Mandelbaum J, Salat-Baroux J, et al. Expression of leukaemia inhibitory factor receptor subunits LIFR β and gp130 in human oocytes and preimplantation embryos. Mol Hum Reprod. 1996;2(5):355-360.
119. Wånggren K, Lalitkumar PG, Hambiliki F, Ståbi B, Gemzell- Danielsson K, Stavreus-Evers A. Leukaemia inhibitory factor receptor and gp130 in the human fallopian tube and endometrium before and after mifepristone treatment and in the human preimplantation embryo. Mol Hum Reprod. 2007;13(6):391-397.
120. Krüssel JS, Huang HY, Simón C, et al. Single blastomeres within human preimplantation embryos express different amounts of messenger ribonucleic acid for β-actin and interleukin-1 receptor type I. J Clin Endocrinol Metab. 1998; 83(3):953-959.
121. Sjöblom C, Wikland M, Robertson SA. Granulocyte-macrophage colony-stimulating factor (GM-CSF) acts independently of the β common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos. Biol Reprod. 2002;67(6):1817-1823.
122. Kawamura K, Fukuda J, Kodama H, Kumagai J, Kumagai A, Tanaka T. Expression of Fas and Fas ligand mRNA in rat and human preimplantation embryos. Mol Hum Reprod. 2001;7(5):431-436.
123. Osterlund C, Fried G. TGFβ receptor types I and II and the substrate proteins Smad 2 and 3 are present in human oocytes. Mol Hum Reprod. 2000;6(6):498-503.
124. Galán A1, Montaner D, Póo ME, et al. Functional genomics of 5- to 8-cell stage human embryos by blastomere single- cell cDNA analysis. PLoS One. 2010;5(10):e13615.
125. Charnock-Jones DS, Sharkey AM, Fenwick P, Smith SK. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil. 1994;101(2):421-426.
126. Giese B, Roderburg C, Sommerauer M, et al. Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells. J Cell Sci. 2005;118:5129-5140.
127. Ernst M, Novak U, Nicholson SE, Layton JE, Dunn AR. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3. J Biol Chem. 1999;274(14):9729-9737.
128. Sharkey A. Cytokines and implantation. Rev Reprod. 1998;3(1):52- 61.
129. Menezo Y, Guerin P. The mammalian oviduct: biochemistry and physiology. Eur J Obstet Gynecol Reprod Biol. 1997;73(1):99-104.
130. Ménézo YJ, el Mouatassim S, Chavrier M, Servy EJ, Nicolet B. Human oocytes and preimplantation embryos expressmRNAfor growth hormone receptor. Zygote. 2003; 11(4):293-297.
131. Kaye PL, Harvey MB. The role of growth factors in preimplantation development. Prog Growth Factor Res. 1995;6(1):1-24.
132. Patsoula E, Loutradis D, Drakakis P, Michalas L, Bletsa R, Michalas S. Messenger RNA expression for the folliclestimulating hormone receptor and luteinizing hormone receptor in human oocytes and preimplantation-stage embryos. Fertil Steril. 2003;79(5):1187-1193.
133. Altmäe S, Reimand J, Hovatta O, et al. Research resource: interactome ofhumanembryo implantation: identification of gene expression pathways, regulation, and integrated regulatory networks. Mol Endocrinol. 2012;26(1):203-217.
134. Richards JS, Liu Z, Kawai T, et al. Adiponectin and its receptors modulate granulosa cell and cumulus cell functions, fertility, and early embryo development in the mouse and human. Fertil Steril. 2012;98(2):471-479.e1.
135. Kiapekou E, Loutradis D, Patsoula E, et al. Prolactin receptor mRNA expression in oocytes and preimplantation mouse embryos. Reprod Biomed Online. 2005;10(3): 339-346.
136. Wang Q, Zhuang GL, Zhou CQ, et al. Expression of certain HLA-I types in cleavage-stage embryos. Reprod Biomed Online. 2009;18(2):244-250.
137. Yao YQ, Barlow DH, Sargent IL. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J Immunol. 2005;175(12):8379-8385.
138. Shaikly VR, Morrison IE, Taranissi M, et al. Analysis of HLA-G in maternal plasma, follicular fluid, and preimplantation embryos reveal an asymmetric pattern of expression. J Immunol. 2008;180(6):4330-4337.
139. Campbell S, Swann HR, Aplin JD, Seif MW, Kimber SJ, Elstein M. CD44 is expressed throughout pre-implantation human embryo development. Hum Reprod. 1995; 10(2):425-430.
140. Dominguez F, Galan A, Martin JJ, Remohi J, Pellicer A, Simón C. Hormonal and embryonic regulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the human endometrium and the human blastocyst. MolHum Reprod. 2003;9(4):189-198.
141. González RR, Caballero-Campo P, Jasper M, et al. Leptin and leptin receptor are expressed in the human endometrium and endometrial leptin secretion is regulated by the human blastocyst. J Clin Endocrinol Metab. 2000;85(12): 4883-4888.
142. Cikoš S. Adiponectin and its receptors in preimplantation embryo development. Vitam Horm. 2012;90:211-238.
143. Maccarrone M. CB2 receptors in reproduction. Br J Pharmacol. 2008;153(2):189-198.
144. Kimber SJ, Sneddon SF, Bloor DJ, et al. Expression of genes involved in early cell fate decisions in human embryos and their regulation by growth factors. Reproduction. 2008; 135(5):635-647.
145. Kotze D, Kruger TF, Lombard C, Padayachee T, Keskintepe L, Sher G. The effect of the biochemical marker soluble human leukocyte antigen G on pregnancy outcome in assisted reproductive technology-a multicenter study. Fertil Steril. 2013;100(5):1303-1309.
146. Leese HJ, Tay JI, Reischl J, Downing SJ. Formation of fallopian tubal fluid: role of a neglected epithelium. Reproduction. 2001;121(3):339-346.
147. el-Danasouri I, Frances A, Westphal LM. Immunocytochemical localization of transforming growth factor-α and epidermal growth factor receptor in human fallopian tubes and cumulus cells. Am J Reprod Immunol. 1993; 30:82-87.
148. Giudice LC, Dsupin BA, Irwin JC, Eckert RL. Identification of insulin-like growth factor binding proteins in human oviduct. Fertil Steril. 1992;57(2):294-301.
149. Pfeifer TL, Chegini N. Immunohistochemical localization of insulin-like growth factor (IGF-I), IGF-I receptor, and IGF binding proteins 1-4 in human fallopian tube at various reproductive stages. Biol Reprod. 1994;50(2):281-289.
150. Jin HY, Wang ZN. Insulin-like growth factors and their receptors in human fallopian tube in reproductive-age women. Fertil Steril. 2001;75(5):1037-1038.
151. Zhao Y, Chegini N, Flanders KC. Human fallopian tube expresses transforming growth factor (TGF β) isoforms, TGF β type I-III receptor messenger ribonucleic acid and protein, and contains [125I]TGF β-binding sites. J Clin Endocrinol Metab. 1994;79(4):1177-1184.
152. Chegini N, Zhao Y, McLean FW. Expression of messenger ribonucleic acid and presence of immunoreactive proteins for epidermal growth factor (EGF), transforming growth factor α (TGF α) and EGF/TGF α receptors and 125I-EGF binding sites in human fallopian tube. Biol Reprod. 1994; 50(5):1049-1058.
153. Srivastava MD, Lippes J, Srivastava BI. Cytokines of the human reproductive tract. Am J Reprod Immunol. 1996; 36(3):157-166.
154. Keltz MD, Attar E, Buradagunta S, Olive DL, Kliman HJ, Arici A. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in the human fallopian tube. Am J Obstet Gynecol. 1996;175(6):1611-1619.
155. Hess AP, Baston-Buest DM, Schanz A, Hirchenhain J, Bielfeld P, Kruessel JS. Interleukin-1 system in the human fallopian tube-No spatial but a temporal regulation of mRNA and protein expression. Mol Cell Endocrinol. 2009;303:7-12.
156. Huang HY, Chan SH, Wu CH, Wang CW, Lai CH, Soong YK. Interleukin-1 system messenger ribonucleic acid and protein expression in human fallopian tube may be associated with ectopic pregnancy. Fertil Steril. 2005;84(5): 1484-1492.
157. Palter SF, Mulayim N, Senturk L, Arici A. Interleukin-8 in the human fallopian tube. J Clin Endocrinol Metab. 2001; 86(6):2660-2667.
158. Zhao Y, Chegini N. Human fallopian tube expresses granulocyte- macrophage colony stimulating factor (GM-CSF) and GM-CSF α and β receptors and contain immunoreactive GM-CSF protein. J Clin Endocrinol Metab. 1994; 79(2):662-665.
159. Li HZ, Sun X, Stavreus-Evers A, Gemzell-Danielsson K. Effect of mifepristone on the expression of cytokines in the human fallopian tube. Mol Hum Reprod. 2004;10(7): 489-493.
160. Gardner DK, Lane M, Calderon I, Leeton J. Environment of the preimplantation human embryo in vivo: metabolite analysis of oviduct and uterine fluids and metabolism of cumulus cells. Fertil Steril. 1996;65(2):349-353.
161. Tay JI, Rutherford AJ, Killick SR, Maguiness SD, Partridge RJ, Leese HJ. Human tubal fluid: production, nutrient composition and response to adrenergic agents. Hum Reprod. 1997;12(11):2451-2456.
162. Harris SE, Gopichandran N, Picton HM, Leese HJ, Orsi NM.Nutrient concentrations in murine follicular fluid and the female reproductive tract. Theriogenology. 2005; 64(4):992-1006.
163. Downing SJ, Tay JI, Maguiness SD, Watson A, Leese HJ. Effect of inflammatory mediators on the physiology of the human fallopian tube. Hum Fertil (Camb). 2002;5(2):54-60.
164. Lei ZM, Rao CV. Expression of epidermal growth factor (EGF) receptor and its ligands, EGF and transforming growth factor-α, in human fallopian tubes. Endocrinology. 1992;131(2):947-957.
165. Adachi K, Kurachi H, Homma H, et al. Estrogen induces epidermal growth factor (EGF) receptor and its ligands in human fallopian tube: involvement of EGF but not transforming growth factor-α in estrogen-induced tubal cell growth in vitro. Endocrinology. 1995;136(5):2110-2119.
166. Adachi K, Kurachi H, Adachi H, et al. Menstrual cycle specific expression of epidermal growth factor receptors in human fallopian tube epithelium. J Endocrinol. 1995; 147(3):553-563.
167. Flickinger GL, Muechler EK, Mikhail G. Estradiol receptor in the human fallopian tube. Fertil Steril. 1974;25(10): 900-903.
168. Magli G, De Marco I, Sirimarco F. 17-β-Estradiol and progesterone receptors in the human fallopian tubes (preliminary note) [in Italian]. Arch Ostet Ginecol. 1980;85: 81-85.
169. Amso NN, Crow J, Shaw RW. Comparative immunohistochemical study of oestrogen and progesterone receptors in the fallopian tube and uterus at different stages of the menstrual cycle and the menopause. Hum Reprod. 1994; 9(6):1027-1037.
170. Zheng W, Magid MS, Kramer EE, Chen YT. Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol. 1996; 148(1):47-53.
171. Lei ZM, Toth P, Rao CV, Pridham D. Novel coexpression of human chorionic gonadotropin (hCG)/human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endocrinol Metab. 1993;77(3): 863-872.
172. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of themRNAof ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87(6): 2988.
173. Pollow K, Inthraphuvasak J, Manz B, Grill HJ, Pollow B. A comparison of cytoplasmic and nuclear estradiol and progesterone receptors in human fallopian tube and endometrial tissue. Fertil Steril. 1981;36(5):615-622.
174. Saridogan E, Djahanbakhch O, Puddefoot JR, et al. Angiotensin II receptors and angiotensin II stimulation of ciliary activity in human fallopian tube. J Clin Endocrinol Metab. 1996;81(7):2719-2725.
175. Wang H, Guo Y, Wang D, et al. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med. 2004;10(10):1074-1080.
176. Schuel H, Burkman LJ, Lippes J, et al. N-Acylethanolamines in human reproductive fluids. Chem Phys Lipids. 2002;121:211-227.
177. Horne AW, Phillips JA 3rd, Kane N, et al. CB1 expression is attenuated in fallopian tube and decidua of women with ectopic pregnancy. PloS One. 2008;3(12):e3969-e3969.
178. Tabibzadeh S, Babaknia A. The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion. Hum Reprod. 1995;10(6):1579- 1602.
179. Lessey BA. Endometrial receptivity and the window of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14(5):775-788.
180. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975;122(2):262-263.
181. Nikas G. Cell-surface morphological events relevant to human implantation. Hum Reprod. 1999;14(suppl 2):37- 44.
182. Bischof P, Campana A. Molecular mediators of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000; 14(5):801-814.
183. Godkin JD, Doré JJ. Transforming growth factorβ and the endometrium. Rev Reprod. 1998;3(1):1- 6.
184. Feinberg RF, Kliman HJ, Wang CL. Transforming growth factor-β stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo. J Clin Endocrinol Metab. 1994;78(5):1241-1248.
185. Chung IB, Yelian FD, Zaher FM, et al. Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line. Placenta. 2000;21(4):320-324.
186. Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-β, IGF-II, and IGFBP-1. Exp Cell Res. 1995;217(2): 419-427.
187. Tamada H, McMaster MT, Flanders KC, Andrews GK, Dey SK. Cell type-specific expression of transforming growth factor-β 1 in the mouse uterus during the periimplantation period. Mol Endocrinol. 1990;4(7):965-972.
188. Jones RL, Salamonsen LA, Critchley HO, Rogers PA, Affandi B, Findlay JK. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception. Mol Hum Reprod. 2000;6(12):1107-1117.
189. Jones RL, Salamonsen LA, Findlay JK. Potential roles for endometrial inhibins, activins and follistatin duringhuman embryo implantation and early pregnancy. Trends Endocrinol Metab. 2002;13(4):144-150.
190. Jones RL, Findlay JK, Farnworth PG, Robertson DM, Wallace E, Salamonsen LA. Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology. 2006;147(2):724-732.
191. Stoikos CJ, Salamonsen LA, Hannan NJ, O'Connor AE, Rombauts L, Dimitriadis E. Activin A regulates trophoblast cell adhesive properties: implications for implantation failure in women with endometriosis-associated infertility. Hum Reprod. 2010;25(7):1767-1774.
192. Hofmann GE, Scott RT Jr, Bergh PA, Deligdisch L. Immunohistochemical localization of epidermal growth factor in human endometrium, decidua, and placenta. J Clin Endocrinol Metab. 1991;73(4):882-887.
193. Haining RE, Schofield JP, Jones DS, Rajput-Williams J, Smith SK. Identification of mRNA for epidermal growth factor and transforming growth factor-α present in low copy number in human endometrium and decidua using reverse transcriptase-polymerase chain reaction. J Mol Endocrinol. 1991;6(3):207-214.
194. Birdsall MA, Hopkisson JF, Grant KE, Barlow DH, Mardon HJ. Expression of heparin-binding epidermal growth factor messenger RNA in the human endometrium. Mol Hum Reprod. 1996;2(1):31-34.
195. Lessey BA, Gui Y, Apparao KB, Young SL, Mulholland J. Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation. Mol Reprod Dev. 2002;62(4):446-455.
196. Stavreus-Evers A, Aghajanova L, Brismar H, Eriksson H, Landgren BM, Hovatta O. Co-existence of heparin-binding epidermal growth factor-like growth factor and pinopodes in human endometrium at the time of implantation. Mol Hum Reprod. 2002;8(8):765-769.
197. Wang XN, Das SK, Damm D, Klagsbrun M, Abraham JA, Dey SK. Differential regulation of heparin-binding epidermal growth factor-like growth factor in the adult ovariectomized mouse uterus by progesterone and estrogen. Endocrinology. 1994;135(3):1264-1271.
198. Simón C, Martín JC, Pellicer A. Paracrine regulators of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14(5):815-826.
199. Yoo HJ, Barlow DH, Mardon HJ. Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation. Dev Genet. 1997;21(1):102-108.
200. Guler HP, Zapf J, Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. New Engl J Med. 1987;317(3):137-140.
201. Rechler MM, Nissley SP. The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol. 1985;47:425-442.
202. Lammers R, Gray A, Schlessinger J, Ullrich A. Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains. EMBO J. 1989;8(5):1369-1375.
203. Zhou J, Dsupin BA, Giudice LC, Bondy CA. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J Clin Endocrinol Metab. 1994;79(6):1723-1734.
204. Gao JG, Zhu HH, Fan J, Mazella J, Tseng L. Progestin and antiprogestin differentially regulate the expression of insulin- like growth factors (IGF-I and IGF-II) messenger ribonucleic acid in human endometrial stromal cells. Biol Reprod. 1995;53(2):355-360.
205. Rutanen EM, Pekonen F. Insulin-like growth factor binding protein-1 in human endometrial function. In: Spencer EM, ed. Modern Concepts of Insulin-Like Growth Factors. New York, NY: Elsevier; 1991:285-294.
206. Giudice LC, Milkowski DA, Lamson G, Rosenfeld RG, Irwin JC. Insulin-like growth factor binding proteins in human endometrium: steroid-dependent messenger ribonucleic acid expression and protein synthesis. J Clin Endocrinol Metab. 1991;72(4):779-787.
207. Julkunen M, Koistinen R, Suikkari AM, Seppälä M, Jänne OA. Identification by hybridization histochemistry of human endometrial cells expressing mRNAs encoding a uterine β-lactoglobulin homologue and insulin-like growth factor-binding protein-1. Mol Endocrinol. 1990;4(5): 700-707.
208. Simón C, Frances A, Pellicer A, Polan ML. Cytokines in Implantation. Semin Reprod Endocrinol. 1995;13(2): 142-151.
209. Song H, Lim H, Das SK, Paria BC, Dey SK. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Mol Endocrinol. 2000;14(8):1147-1161.
210. Arici A, Engin O, Attar E, Olive DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab. 1995;80(6):1908-1915.
211. Kojima K, Kanzaki H, Iwai M, et al. Expression of leukemia inhibitory factor inhumanendometrium and placenta. Biol Reprod. 1994;50(4):882-887.
212. Cullinan EB, Abbondanzo SJ, Anderson PS, Pollard JW, Lessey BA, Stewart CL. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci USA. 1996; 93(7):3115-3120.
213. Vogiagis D, Marsh MM, Fry RC, Salamonsen LA. Leukaemia inhibitory factor in human endometrium throughout the menstrual cycle. J Endocrinol. 1996;148(1):95- 102.
214. Dimitriadis E, Salamonsen LA, Robb L. Expression of interleukin-11 during the human menstrual cycle: coincidence with stromal cell decidualization and relationship to leukaemia inhibitory factor and prolactin. Mol Hum Reprod. 2000;6(10):907-914.
215. Brinsden PR, Alam V, de Moustier B, Engrand P. Recombinant human leukemia inhibitory factor does not improve implantation and pregnancy outcomes after assisted reproductive techniques in women with recurrent unexplained implantation failure. Fertil Steril. 2009;91(4 suppl):1445-1447.
216. von Wolff M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines inhuman endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod. 2000;6(7): 627-634.
217. Vandermolen DT, Gu Y. Human endometrial interleukin-6 (IL-6): in vivo messenger ribonucleic acid expression, in vitro protein production, and stimulation thereof by IL-1 β. Fertil Steril. 1996;66(5):741-747.
218. Cork BA, Li TC, Warren MA, Laird SM. Interleukin-11 (IL-11) inhumanendometrium: expression throughout the menstrual cycle and the effects of cytokines on endometrial IL-11 production in vitro. J Reprod Immunol. 2001;50(1): 3-17.
219. von Rango U, Alfer J, Kertschanska S, et al. Interleukin-11 expression: its significance in eutopic and ectopic human implantation. Mol Hum Reprod. 2004;10(11):783-792.
220. Linjawi S, Li TC, Tuckerman EM, Blakemore AI, Laird SM. Expression of interleukin-11 receptor α and interleukin-11 protein in the endometrium of normal fertile women and women with recurrent miscarriage. J Reprod Immunol. 2004;64:145-155.
221. Sueoka K, Shiokawa S, Miyazaki T, Kuji N, Tanaka M, Yoshimura Y. Integrins and reproductive physiology: expression and modulation in fertilization, embryogenesis, and implantation. Fertil Steril. 1997;67(5):799-811.
222. Lessey BA, Ilesanmi AO, Lessey MA, Riben M, Harris JE, Chwalisz K. Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: implications for implantation, contraception, and infertility. Am J Reprod Immunol. 1996;35(3):195- 204.
223. Aplin JD, Spanswick C, Behzad F, Kimber SJ, Vićovac L. Integrins β 5, β 3 and α v are apically distributed in endometrial epithelium. Mol Hum Reprod. 1996;2(7):527-534.
224. Nardo LG, Nikas G, Makrigiannakis A, et al. Synchronous expression of pinopodes and alpha v beta 3 and alpha 4 beta 1 integrins in the endometrial surface epithelium of normally menstruating women during the implantation window. J Reprod Med. 2003;48(5):355-361.
225. Fässler R, Meyer M. Consequences of lack of β 1 integrin gene expression in mice. Genes Dev. 1995;9(15):1896-1908.
226. Stephens LE, Sutherland AE, Klimanskaya IV, et al. Deletion ofβ 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev. 1995;9(15): 1883-1895.
227. Yang JT, Rayburn H, Hynes RO. Cell adhesion events mediated by α 4 integrins are essential in placental and cardiac development. Development. 1995;121(2):549-560.
228. Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in α 5 integrin-deficient mice. Development. 1993; 119(4):1093-1105.
229. Gimond C, Baudoin C, van der Neut R, Kramer D, Calafat J, Sonnenberg A. Cre-loxP-mediated inactivation of the α6A integrin splice variant in vivo: evidence for a specific functional role of α6A in lymphocyte migration but not in heart development. J Cell Biol. 1998;143(1):253-266.
230. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, et al. β3- Integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999;103(2):229-238.
231. Hey NA, Graham RA, Seif MW, Aplin JD. The polymorphic epithelial mucin MUC1 in human endometrium is regulated with maximal expression in the implantation phase. J Clin Endocrinol Metab. 1994;78(2):337-342.
232. Hey NA, Li TC, Devine PL, Graham RA, Saravelos H, Aplin JD. MUC1 in secretory phase endometrium: expression in precisely dated biopsies and flushings from normal and recurrent miscarriage patients. Hum Reprod. 1995; 10(10):2655-2662.
233. Hey NA, Aplin JD. Sialyl-Lewis x and Sialyl-Lewis a are associated withMUC1inhumanendometrium. Glycoconj J. 1996;13(5):769-779.
234. Meseguer M, Aplin JD, Caballero-Campo P, et al. Human endometrial mucinMUC1is up-regulated by progesterone and down-regulated in vitro by the human blastocyst. Biol Reprod. 2001;64(2):590-601.
235. Kumar S, Zhu LJ, PolihronisM,et al. Progesterone induces calcitonin gene expression in human endometrium within the putative window of implantation. J Clin Endocrinol Metab. 1998;83(12):4443-4450.
236. Taylor HS, Vanden Heuvel GB, Igarashi P. A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod. 1997;57(6):1338-1345.
237. Taylor HS, Arici A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest. 1998; 101(7):1379-1384.
238. Taylor HS, Bagot C, Kardana A, Olive D, Arici A. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod. 1999;14(5):1328-1331.
239. Xu B, Geerts D, Bu Z, et al. Regulation of endometrial receptivity by the highly expressed HOXA9, HOXA11 and HOXD10HOX-class homeobox genes.HumReprod. 2014;29(4):781-790.
240. Bui TD, Zhang L, Rees MC, Bicknell R, Harris AL. Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Br J Cancer. 1997;75(8):1131-1136.
241. Tulac S, Nayak NR, Kao LC, et al. Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab. 2003;88(8):3860-3866.
242. Carson DD, Lagow E, Thathiah A, et al. Changes in gene expression during the early to mid-luteal (receptive phase) transition inhumanendometrium detected by high-density microarray screening. Mol Hum Reprod. 2002;8(9):871-879.
243. Kao LC, Tulac S, Lobo S, et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology. 2002;143(6):2119-2138.
244. Borthwick JM, Charnock-Jones DS, Tom BD, et al. Determination of the transcript profile of human endometrium. Mol Hum Reprod. 2003;9(1):19-33.
245. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab. 1988; 67(2):334-340.
246. Lessey BA, Metzger DA, Haney AF, McCarty KS. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril. 1989;51(3):409-415.
247. Gellersen B, Fernandes MS, Brosens JJ. Non-genomic progesterone actions in female reproduction. Hum Reprod Update. 2009;15(1):119-138.
248. Lutz M, Knaus P. Integration of the TGF-β pathway into the cellular signalling network. Cell Signal. 2002;14(12): 977-988.
249. Dey SK, Lim H, Das SK, et al. Molecular cues to implantation. Endocr Rev. 2004;25(3):341-373.
250. Salamonsen LA, Hannan NJ, Dimitriadis E. Cytokines and chemokines during human embryo implantation: roles in implantation and early placentation. Semin Reprod Med. 2007;25(6):437-444.
251. Duc-Goiran P, MignotTM,Bourgeois C, Ferré F. Embryomaternal interactions at the implantation site: a delicate equilibrium. Eur J Obstet Gynecol Reprod Biol. 1999; 83(1):85-100.
252. Hannan NJ, Evans J, Salamonsen LA. Alternate roles for immune regulators: establishing endometrial receptivity for implantation. Expert Rev Clin Immunol. 2011;7(6): 789-802.
253. Weimar CH, Post Uiterweer ED, Teklenburg G, Heijnen CJ, Macklon NS. In-vitro model systems for the study of human embryo-endometrium interactions. Reprod Biomed Online. 2013;27(5):461-476.
254. Fong CY, Bongso A. Comparison of human blastulation rates and total cell number in sequential culture media with and without co-culture. Hum Reprod. 1999;14(3):774- 781.
255. Dominguez F, Gadea B, Mercader A, Esteban FJ, Pellicer A, Simón C. Embryologic outcome and secretome profile of implanted blastocysts obtained after coculture in human endometrial epithelial cells versus the sequential system. Fertil Steril. 2010;93(3):774-782.e1.
256. Simón C, Mercader A, Garcia-Velasco J, et al. Coculture of human embryos with autologous human endometrial epithelial cells in patients with implantation failure. J Clin Endocrinol Metab. 1999;84(8):2638-2646.
257. Mercader A, Garcia-Velasco JA, Escudero E, Remohí J, Pellicer A, Simón C. Clinical experience and perinatal outcome of blastocyst transfer after coculture of human embryos with human endometrial epithelial cells: a 5-year follow-up study. Fertil Steril. 2003;80(5):1162-1168.
258. Caballero-Campo P, Domínguez F, Coloma J, et al. Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation. Mol Hum Reprod. 2002; 8(4):375-384.
259. Dominguez F, Simón C, Quiñonero A, et al. Human endometrial CD98 is essential for blastocyst adhesion. PLoS One. 2010;5(10):e13380.
260. Way DL, Grosso DS, Davis JR, Surwit EA, Christian CD. Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro. 1983;19: 147-158.
261. Satyaswaroop PG, Tabibzadeh SS. Extracellular matrix and the patterns of differentiation of human endometrial carcinomas in vitro and in vivo. Cancer Res. 1991;51(20): 5661-5666.
262. CCM-30. Product information. Göteborg, Sweden: 2011. Vitrolife; http://www.vitrolife.com/en/Fertility/ Products/Additional-media-and-solutions-/CCM/. Date accessed: November, 2014.
263. Lopata A, Oliva K. Chorionic gonadotrophin secretion by human blastocysts. Hum Reprod. 1993;8(6):932-938.
264. Spanos S, Becker DL, Winston RM, Hardy K. Anti-apoptotic action of insulin-like growth factor-I during human preimplantation embryo development. Biol Reprod. 2000; 63(5):1413-1420.
265. Martin KL, Barlow DH, Sargent IL. Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium. Hum Reprod. 1998;13(6):1645-1652.
266. O'Neill C, Ryan JP, Collier M, Saunders DM, Ammit AJ, Pike IL. Supplementation of in-vitro fertilisation culture medium with platelet activating factor. Lancet. 1989; 2(8666):769-772.
267. O'Neill C. The role of paf in embryo physiology. Hum Reprod Update. 2005;11(3):215-228.
268. Ammit AJ, O'Neill C. Optimization of a method for deactivation of platelet-activating factor: acetylhydrolase in serum for use in in-vitro fertilization culture media. Hum Reprod. 1997;12(4):785-791.
269. Vercammen M, Verloes A, Haentjens P, Van de Velde H. Can soluble human leucocyte antigen-G predict successful pregnancy in assisted reproductive technology? Curr Opin Obstet Gynecol. 2009;21(3):285-290.
270. Sargent I, Swales A, Ledee N, Kozma N, Tabiasco J, Le Bouteiller P. sHLA-G production by human IVF embryos: can it be measured reliably? J Reprod Immunol. 2007; 75(2):128-132.
271. Sjöblom C, Wikland M, Robertson SA. Granulocyte-macrophage colony-stimulating factor promotes human blastocyst development in vitro. Hum Reprod. 1999;14(12): 3069-3076.
272. Sjöblom C, Wikland M, Robertson SA. Granulocyte-macrophage- colony stimulating factor (GM-CSF) promotes inner cell mass blastomere viability in human pre-implantation embryos. Fertil Steril. 2001;76(3 suppl 1):S70.
273. Shapiro BS, Richter KS, Daneshmand ST, Quinn P, Behr B. Granulocyte-macrophage colony-stimulating factor enhances human embryo development to the blastocyst stage: a randomized study. Fertil Steril. 2003;79(suppl 2): 15-16.
274. Sjöblom C, Roberts CT, Wikland M, Robertson SA. Granulocyte- macrophage colony-stimulating factor alleviates adverse consequences of embryo culture on fetal growth trajectory and placental morphogenesis. Endocrinology. 2005;146(5):2142-2153.
275. Elaimi A, Gardner K, Kistnareddy K, Harper J. The effect of GM-CSF on development and aneuploidy in murine blastocysts. Hum Reprod. 2012;27(6):1590-1595.
276. Agerholm I, Loft A, Hald F, et al. Culture ofhumanoocytes with granulocyte-macrophage colony-stimulating factor has no effect on embryonic chromosomal constitution. Reprod Biomed Online. 2010;20(4):477-484.
277. Kim D, Kim M, Kang H, Lee H, Park W, Kwon H. The supplementation of granulocyte-macrophage colony stimulating factor (GM-CSF) in culture medium improves the pregnancy rate in human ART programs. Fertil Steril. 2001;76(3: suppl 1):S6.
278. Ziebe S, Loft A, Povlsen BB, et al. A randomized clinical trial to evaluate the effect of granulocyte-macrophage colony- stimulating factor (GM-CSF) in embryo culture medium for in vitro fertilization. Fertil Steril. 2013;99(6): 1600-1609.
279. Dunglison GF, Barlow DH, Sargent IL. Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium. Hum Reprod. 1996;11(1):191-196.
280. Jurisicova A, Ben-Chetrit A, Varmuza SL, Casper RF. Recombinant human leukemia inhibitory factor does not enhance in vitro human blastocyst formation. Fertil Steril. 1995;64(5):999-1002.
281. Hambiliki F, Hanrieder J, Bergquist J, Hreinsson J, Stavreus-Evers A, Wånggren K. Glycoprotein 130 promotes human blastocyst development in vitro. Fertil Steril. 2013;99(6):1592-1599.
282. Piestrzeniewicz-Ulanska D, Brys M, Semczuk A, Jakowicki JA, Krajewska WM. Expression of TGF-β type I and II receptors in normal and cancerous human endometrium. Cancer Lett. 2002;186(2):231-239.
283. Gardner DK. Dissection of culture media for embryos: the most important and less important components and characteristics. Reprod Fertil Dev. 2008;20(1):9-18.
284. Gardner DK, Pool TB, Lane M. Embryo nutrition and energy metabolism and its relationship to embryo growth, differentiation, and viability. Semin Reprod Med. 2000; 18(2):205-218.
285. Gardner DK, Lane M. Culture of viable human blastocysts in defined sequential serum-free media. Hum Reprod. 1998;13(suppl 3):148-159; discussion 160.
286. Morbeck DE, Krisher RL, Herrick JR, Baumann NA, Matern D, Moyer T. Composition of commercial media used for human embryo culture. Fertil Steril. 2014;102(3):759- 766.e9.
287. Dyrlund TF, Kirkegaard K, Poulsen ET, et al. Unconditioned commercial embryo culture media contain a large variety of non-declared proteins: a comprehensive proteomics analysis. Hum Reprod. 2014;29(11):2421-2430.
288. Menezo Y, Testart J, Perrone D. Serum is not necessary in human in vitro fertilization, early embryo culture, and transfer. Fertil Steril. 1984;42(5):750-755.
289. Weathersbee PS, Pool TB, Ord T. Synthetic serum substitute (SSS): a globulin-enriched protein supplement for human embryo culture. J Assist Reprod Genet. 1995;12(6): 354-360.
290. Laverge H, De Sutter P, Desmet R, Van der Elst J, Dhont M. Prospective randomized study comparing human serum albumin with fetal cord serum as protein supplement in culture medium for in-vitro fertilization. Hum Reprod. 1997;12(10):2263-2266.
291. Gray CW, Morgan PM, Kane MT. Purification of an embryotrophic factor from commercial bovine serum albumin and its identification as citrate. J Reprod Fertil. 1992; 94(2):471-480.
292. Bungum M, Humaidan P, Bungum L. Recombinant human albumin as protein source in culture media used for IVF: a prospective randomized study. Reprod Biomed Online. 2002;4(3):233-236.
293. Salamonsen LA, Shuster S, Stern R. Distribution of hyaluronan in human endometrium across the menstrual cycle. Implications for implantation and menstruation. Cell Tissue Res. 2001;306(2):335-340.
294. Urman B, Yakin K, Ata B, Isiklar A, Balaban B. Effect of hyaluronan-enriched transfer medium on implantation and pregnancy rates after day 3 and day 5 embryo transfers: a prospective randomized study. Fertil Steril. 2008; 90(3):604-612.
295. Bontekoe S, Heineman MJ, Johnson N, Blake D. Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane Database Syst Rev. 2014;2:CD007421.
296. Hurst PR, Leeuwenberg BR, Ellis LM. Stereological study of mouse uterine and in vitro grown blastocysts: cell numbers and volumes. Anat Rec. 1993;236(2):411-416.
297. Giritharan G, Delle Piane L, Donjacour A, et al. In vitro culture of mouse embryos reduces differential gene expression between inner cell mass and trophectoderm. Reprod Sci. 2012;19(3):243-252.
298. Market-Velker BA, Fernandes AD, Mann MR. Side-byside comparison of five commercial media systems in a mouse model: suboptimal in vitro culture interferes with imprint maintenance. Biol Reprod. 2010;83(6):938-950.
299. Lazaraviciute G, Kauser M, Bhattacharya S, Haggarty P, Bhattacharya S. A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously. Hum Reprod Update. 2014;20(6): 840-852.
300. Buster JE, BustilloM,Thorneycroft IH, et al. Non-surgical transfer of in vivo fertilised donated ova to five infertile women: report of two pregnancies. Lancet. 1983;2(8343): 223-224.
301. Bustillo M, Buster JE, Cohen SW, et al. Delivery of a healthy infant following nonsurgical ovum transfer. JAMA. 1984;251(7):889.
302. Buster JE, Bustillo M, Rodi IA, et al. Biologic and morphologic development of donated human ova recovered by nonsurgical uterine lavage. Am J Obstet Gynecol. 1985; 153(2):211-217.
303. Formigli L, Formigli G, Roccio C. Donation of fertilized uterine ova to infertile women. Fertil Steril. 1987;47(1): 162-165.
304. Sauer MV, Bustillo M, Rodi IA, Gorrill MJ, Buster JE. In-vivo blastocyst production and ovum yield among fertile women. Hum Reprod. 1987;2(8):701-703.
305. Sauer MV, Bustillo M, Gorrill MJ, Louw JA, Marshall JR, Buster JE. An instrument for the recovery of preimplantation uterine ova. Obstet Gynecol. 1988;71(5):804-806.
306. Formigli L, Roccio C, Belotti G, Stangalini A, Coglitore MT, Formigli G. Non-surgical flushing of the uterus for pre-embryo recovery: possible clinical applications. Hum Reprod. 1990;5(3):329-335.
307. Previvo. Product information. San Jose, CA: Previvo Genetics; 2014. http://previvogenetics.com/.
308. Anecova. Product information. Lausanne, Switzerland: Anecova; 2009. http://www.anecova.com/.
309. Blockeel C, Mock P, Verheyen G, et al. An in vivo culture system for human embryos using an encapsulation technology: a pilot study. Hum Reprod. 2009;24(4):790-796.
310. Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev. 2013;7:CD003416.
311. Machtinger R, Racowsky C. Morphological systems of human embryo assessment and clinical evidence. Reprod Biomed Online. 2013;26(3):210-221.
312. Clarke RN, Baltz JM, Lechene CP, Biggers JD. Use of ultramicrofluorometric methods for the study of single preimplantation embryos. Poult Sci. 1989;68(7):972-978.
313. Barnett DK, Bavister BD. What is the relationship between the metabolism of preimplantation embryos and their developmental competence? Mol Reprod Dev. 1996;43(1): 105-133.
314. Gardner DK, Wale PL, Collins R, Lane M. Glucose consumption of single post-compaction human embryos is predictive of embryo sex and live birth outcome. Hum Reprod. 2011;26(8):1981-1986.
315. Guerif F, McKeegan P, Leese HJ, Sturmey RG. A simple approach for COnsumption and RElease (CORE) analysis of metabolic activity in single mammalian embryos. PLoS One. 2013;8(8):e67834.
316. Desai N, Filipovits J, Goldfarb J. Secretion of soluble HLA-G by day 3 human embryos associated with higher pregnancy and implantation rates: assay of culture media using a new ELISA kit. Reprod Biomed Online. 2006; 13(2):272-277.
317. Hollywood K, Brison DR, Goodacre R. Metabolomics: current technologies and future trends. Proteomics. 2006; 6(17):4716-4723.
318. Hardarson T, Ahlström A, Rogberg L, et al. Non-invasive metabolomic profiling of day 2 and 5 embryo culture medium: a prospective randomized trial.HumReprod. 2012; 27(1):89 -96.
319. Seli E, Sakkas D, Scott R, Kwok SC, Rosendahl SM, Burns DH. Noninvasive metabolomic profiling of embryo culture media using Raman and near-infrared spectroscopy correlates with reproductive potential of embryos in womenundergoing in vitro fertilization. Fertil Steril. 2007; 88(5):1350-1357.
320. Vergouw CG, Kieslinger DC, Kostelijk EH, et al. Day 3 embryo selection by metabolomic profiling of culture medium with near-infrared spectroscopy as an adjunct to morphology: a randomized controlled trial. Hum Reprod. 2012;27(8):2304-2311.
321. Cortezzi SS, Garcia JS, Ferreira CR, et al. Secretome of the preimplantation human embryo by bottom-up label-free proteomics. Anal Bioanal Chem. 2011;401(4):1331-1339.
322. Cortezzi SS, Cabral EC, Trevisan MG, et al. Prediction of embryo implantation potential by mass spectrometry fingerprinting of the culture medium. Reproduction. 2013; 145(5):453-462.
323. Stigliani S, Anserini P, Venturini PL, Scaruffi P. Mitochondrial DNA content in embryo culture medium is significantly associated with human embryo fragmentation. Hum Reprod. 2013;28(10):2652-2660.
324. Lessey BA, Damjanovich L, Coutifaris C, Castelbaum A, Albelda SM, Buck CA. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J Clin Invest. 1992;90(1):188- 195.
325. Meseguer M, Pellicer A, Simón C. MUC1 and endometrial receptivity. Mol Hum Reprod. 1998;4(12):1089-1098.
326. Stewart CL, Kaspar P, Brunet LJ, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 1992;359(6390):76-79.
327. Giudice LC. Microarray expression profiling reveals candidate genes for human uterine receptivity. Am J Pharmacogenomics. 2004;4(5):299-312.
328. Diaz-Gimeno P, Horcajadas JA, Martinez-Conejero JA, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95(1):50-60, 60.e15.
329. Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, et al. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertil Steril. 2013;100(3):818-824.
330. Domínguez F, Garrido-Gómez T, López JA, et al. Proteomic analysis of the human receptive versus non-receptive endometrium using differential in-gel electrophoresis and MALDI-MS unveils stathmin 1 and annexin A2 as differentially regulated.HumReprod. 2009;24(10):2607- 2617.
331. Ruiz-Alonso M, Galindo N, Pellicer A, Simón C. What a difference two days make: "personalized" embryo transfer (pET) paradigm: a case report and pilot study. Hum Reprod. 2014;29(6):1244-1247.
332. Parmar T, Gadkar-Sable S, Savardekar L, et al. Protein profiling of human endometrial tissues in the midsecretory and proliferative phases of the menstrual cycle. Fertil Steril. 2009;92(3):1091-1103.
333. Hannan NJ, Stephens AN, Rainczuk A, Hincks C, Rombauts LJ, Salamonsen LA. 2D-DiGE analysis of the human endometrial secretome reveals differences between receptive and nonreceptive states in fertile and infertile women. J Proteome Res. 2010;9(12):6256-6264.
334. Hannan NJ, Paiva P, Meehan KL, Rombauts LJ, Gardner DK, Salamonsen LA. Analysis of fertility-related soluble mediators in human uterine fluid identifies VEGF as a key regulator of embryo implantation. Endocrinology. 2011; 152(12):4948-4956.
335. Berlanga O, Bradshaw HB, Vilella-Mitjana F, Garrido- GómezT, Simón C.Howendometrial secretomics can help in predicting implantation. Placenta. 2011;32(suppl 3): S271-S275.
336. van der Gaast MH, Beier-Hellwig K, Fauser BC, Beier HM, Macklon NS. Endometrial secretion aspiration prior to embryo transfer does not reduce implantation rates. Reprod Biomed Online. 2003;7(1):105-109.
337. Boomsma CM, Kavelaars A, Eijkemans MJ, et al. Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod. 2009;24(6): 1427-1435.
338. Vilella F, Ramirez LB, Simón C. Lipidomics as an emerging tool to predict endometrial receptivity. Fertil Steril. 2013; 99(4):1100-1106.
339. Achache H, Tsafrir A, Prus D, Reich R, Revel A. Defective endometrial prostaglandin synthesis identified in patients with repeated implantation failure undergoing in vitro fertilization. Fertil Steril. 2010;94(4):1271-1278.
340. Vilella F, Ramirez L, Berlanga O, et al. PGE2 and PGF2α concentrations in human endometrial fluid as biomarkers for embryonic implantation. J Clin Endocrinol Metab. 2013;98(10):4123-4132.
341. Pellicer A, Simón C, Remohí J. Effects of aging on the female reproductive system. Hum Reprod. 1995;10(suppl 2):77-83.
342. Díaz-Gimeno P, Ruiz-Alonso M, Blesa D, et al. The accuracy and reproducibility of the endometrial receptivity array is superior to histology as a diagnostic method for endometrial receptivity. Fertil Steril. 2013;99(2):508-517.
343. Boehm KD, Daimon M, Gorodeski IG, Sheean LA, Utian WH, Ilan J. Expression of the insulin-like and plateletderived growth factor genes in human uterine tissues. Mol Reprod Dev. 1990;27(2):93-101.
344. Tabibzadeh S, Kong QF, Babaknia A, May LT. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window. Hum Reprod. 1995;10(10):2793-2799.
345. Ulukus M, Ulukus EC, Tavmergen Goker EN, Tavmergen E, Zheng W, Arici A. Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis. Fertil Steril. 2009;91(3):687-693.
346. Chegini N, Ma C, Roberts M, Williams RS, Ripps BA. Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion. J Reprod Immunol. 2002;56:93-110.
347. Guzeloglu-Kayisli O, Kayisli UA, Taylor HS. The role of growth factors and cytokines during implantation: endocrine and paracrine interactions. Semin Reprod Med. 2009;27(1):62-79.
348. Carrarelli P, Rocha AL, Belmonte G, et al. Increased expression of antimüllerian hormone and its receptor in endometriosis. Fertil Steril. 2014;101(5):1353-1358.
349. Möller B, Rasmussen C, Lindblom B, Olovsson M. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod. 2001;7(1): 65-72.
350. Haider S, KnöflerM.Humantumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30(2):111-123.
351. Serafini P, Da Rocha AM, De Toledo Osório CA, et al. Protein profile of the luteal phase endometrium by tissue microarray assessment. Gynecol Endocrinol. 2009;25(9): 587-592.
352. Pampfer S, Arceci RJ, Pollard JW. Role of colony stimulating factor-1 (CSF-1) and other lympho-hematopoietic growth factors in mouse pre-implantation development. Bioessays. 1991;13(10):535-540.
353. Zhao Y, Chegini N. The expression of granulocyte macrophage- colony stimulating factor (GM-CSF) and receptors in human endometrium. Am J Reprod Immunol. 1999;42(5):303-311.
354. Giacomini G, Tabibzadeh SS, Satyaswaroop PG, et al. Epithelial cells are the major source of biologically active granulocyte macrophage colony-stimulating factor in hu man endometrium. Hum Reprod. 1995;10(12):3259-3263.
355. Ejskjaer K, Sørensen BS, Poulsen SS, Mogensen O, Forman A, Nexø E. Expression of the epidermal growth factor system in human endometrium during the menstrual cycle. Mol Hum Reprod. 2005;11(8):543-551.
356. Chegini N, Dou Q, Williams RS. An inverse relation between the expression of tumor necrosis factor α (TNF-α) and TNF-α receptor in human endometrium.AmJ Reprod Immunol. 1999;42(5):297-302.
357. Krüssel JS, Casañ EM, Raga F, et al. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometrium. Mol Hum Reprod. 1999; 5(5):452-458.
358. Mioni R, Mozzanega B, Granzotto M, et al. Insulin receptor and glucose transporters mRNA expression throughout the menstrual cycle in human endometrium: a physiological and cyclical condition of tissue insulin resistance. Gynecol Endocrinol. 2012;28(12):1014-1018.
359. Tang XM, Rossi MJ, Masterson BJ, Chegini N. Insulinlike growth factor I (IGF-I), IGF-I receptors, and IGF binding proteins 1-4 in human uterine tissue: tissue localization and IGF-I action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol Reprod. 1994;50(5):1113-1125.
360. Takemura M, Nomura S, Kimura T, et al. Expression and localization of oxytocin receptor gene in human uterine endometrium in relation to the menstrual cycle. Endocrinology. 1993;132(4):1830-1835.
361. Sbracia M, Scarpellini F, Poverini R, Alò PL, Rossi G, Di Tondo U. Immunohistochemical localization of the growth hormone in human endometrium and decidua. Am J Reprod Immunol. 2004;51(2):112-116.
362. Martinez LB, Leyva MZ, Romero IC. Prolactin receptor in human endometriotic tissues. Acta Obstet Gynecol Scand. 2002;81(1):5-10.
363. Hoshi S, Morimoto T, Saito H, et al. PTHrP and PTH/ PTHrP receptor expressions in human endometrium. Endocr J. 2001;48(2):219-225.
364. Licht P, von Wolff M, Berkholz A, Wildt L. Evidence for cycle-dependent expression of full-lengthhumanchorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril. 2003; 79(suppl 1):718-723.
365. La Marca A, Carducci Artenisio A, Stabile G, Rivasi F, Volpe A. Evidence for cycle-dependent expression of follicle- stimulating hormone receptor in human endometrium. Gynecol Endocrinol. 2005;21(6):303-306.
366. Aghajanova L, Stavreus-Evers A, Lindeberg M, Landgren BM, Sparre LS, Hovatta O. Thyroid-stimulating hormone receptor and thyroid hormone receptors are involved in human endometrial physiology. Fertil Steril. 2011;95(1): 230-237.e2.
367. Vandermolen DT, Gu Y. Human endometrial expression of granulocyte colony-stimulating factor (G-CSF) and its receptor, stimulation of endometrial G-CSF production by interleukin-1 β, and G-CSF inhibition of choriocarcinoma cell proliferation. Am J Reprod Immunol. 1996;36(5): 278-284.
368. Chegini N, Rossi MJ, Masterson BJ. Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGF β-receptors in human endometrial tissue: localization and in vitro action. Endocrinology. 1992;130(4):2373-2385.